Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice

Virology

Volumn 244, Issue 1, 1998, Pages 59-65

  Ryman, Kate D ^a   Ledger, T Neil ^b   Campbell, Gerald A ^a   Watowich, Stanley J ^a   Barrett, Alan D T ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

17D 204 substrain specific epitope; Envelope protein; Yellow fever virus

Indexed keywords

EPITOPE; VIRUS VACCINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; HISTOPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS MUTANT; VIRUS VIRULENCE; YELLOW FEVER FLAVIVIRUS;

ANIMALIA; FLAVIVIRUS; RNA VIRUSES; YELLOW FEVER VIRUS;

EID: 0032565395     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9057     Document Type: Article

References (26)

1. Barrett A. D. T, Pryde A., Medlen A. R., Ledger T. N., Whitby J. E., Gibson C. A., DeSilva M., Groves D. J., Langley D. J., Minor P. D. Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies. Vaccine. 7:1989;333-336.
2. Buckley A., Gould E. A. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies. J. Gen. Virol. 66:1985;2523-2531.
3. Cammack N., Gould E. A. Topological analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild-type Asibi parent virus. Virology. 150:1986;33-341.
4. Cao J. X., Ni H., Campbell G. A., Sil B. K., Rayman K. D., Kitchen I., Barrett A. D. T. Passage of Japanese encephalitis virus in HeLa cells results in alternation of virulence in mice. J. Gen. Virol. 76:1995;2757-2764.
5. Cecilia D., Gould E. A. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology. 181:1991;70-77.
6. Després P., Ruiz-Linares A., Cahour A., Girard M., Wychowski C., Bouloy M. The 15 amino acid residues preceding the amino terminus of the envelope protein of the yellow fever virus polyprotein precursor act as a signal peptide. Virus Res. 16:1990;59-76.
7. Gould E. A., Buckley A., Cammack N., Barrett A. D. T., Clegg J. C. S., Ishak R., Varma M. G. R. Examination of the immunological relationships between flaviviruses using yellow fever monoclonal antibodies. J. Gen. Virol. 66:1985;1369-1382.
8. Gould E. A., Buckley A., Barrett A. D. T., Cammack N. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J. Gen. Virol. 67:1986;591-595.
9. Gould E. A., Buckley A., Cane P. A., Higgs S., Cammack N. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools. J. Gen. Virol. 70:1989;1889-1894.
10. Guirakhoo F., Bolin R. A., Roehrig J. T. The Murray valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology. 191:1992;921-931.
11. Hahn C. S., Dalrymple J. M., Strauss J. H., Rice C. M. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc. Natl. Acad. Sci. USA. 84:1987;2019-2023.
12. Hasegawa H., Yoshida M., Shiosaka T., Fujita S., Kobayashi Y. Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice. Virology. 191:1992;158-165.
13. Holzmann H., Heinz F. X., Mandl. C. W., Guirakhoo F., Kunz C. W. A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J. Virol. 64:1990;5156-5159.
14. Jennings A. D., Whitby J. E., Minor P. D., Barrett A. D. T. Comparison of the nucleotide and deduced amino acid sequence of the structural protein genes of the yellow fever 17DD vaccine strain from Senegal with that of other yellow fever vaccine viruses. Vaccine. 11:1993;679-681.
15. Jiang W. R., Lowe A., Higgs S., Reid H., Gould E. A. Single amino acid codon changes detected in Louping ill virus antibody-resistant mutants with reduced neurovirulence. J. Gen. Virol. 74:1993;913-935.
16. Lewis J. W., Chang G.-J., Lanciotti R. S., Trent D. W. Direct sequencing of large flavivirus PCR products for analysis of genome variation and molecular epidemiological investigations. J. Virol. Methods. 38:1992;11-24.
17. Lin B., Parrish C. R., Murray J. M., Wright P. J. Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Virology. 202:1994;885-890.
18. Lobigs M., Dalgarno L., Schlesinger J. J., Weir R. E. Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain). Virology. 161:1987;474-478.
19. Mandl C. W., Guirakhoo F., Holzmann H., Heinz F. X., Kunz C. Antigenic structure of the flavivirus envelope protein at the molecular level, using tick-borne encephalitis virus as a model. J. Virol. 63:1989;4070-4077.
20. McMinn P. C., Lee E., Hartley S., Roehrig J. T., Dalgarno L., Weir R. C. Murray Valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice. Virology. 211:1995;10-20.
21. Ni H., Chang G. J. JG. J., Xie H., Trent D. W., Barrett A. D. T. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J. Gen. Virol. 76:1995;409-413.
22. Post P. R., Santos C. N. D., Carvalho R., Cruz A. C. R., Rice C. M., Galler R. Heterogeneity in envelope protein sequences and N-linked glycosylation among yellow fever vaccine strains. Virology. 188:1992;160-167.
23. Rey F. A., Heinz F. X., Mandl C. W., Kunz C., Harrison S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature. 375:1995;291-298.
24. Ryman K. D., Xie H., Ledger T. N., Campbell G. A., Barrett A. D. T. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice. Virology. 230:1997a;376-380.
25. Ryman K. D., Ledger T. N., Weir R. C., Schlesinger J. J., Barrett A. D. T. Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes. J. Gen. Virol. 78:1997b;1353-1356.
26. Wiktor T. J., Koprowski H. Antigenic variants of rabies virus. J. Exp. Med. 152:1980;99-112.